- Home
- CRVS vs MTRX Comparison
CRVS vs MTRX Comparison
Compare CRVS & MTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- MTRX
- Stock Information
- Founded
- CRVS 2014
- MTRX 1984
- Country
- CRVS United States
- MTRX United States
- Employees
- CRVS N/A
- MTRX N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- MTRX Engineering & Construction
- Sector
- CRVS Health Care
- MTRX Consumer Discretionary
- Exchange
- CRVS Nasdaq
- MTRX Nasdaq
- Market Cap
- CRVS 459.0M
- MTRX 405.6M
- IPO Year
- CRVS 2016
- MTRX 1990
- Fundamental
- Price
- CRVS $5.79
- MTRX $12.71
- Analyst Decision
- CRVS Strong Buy
- MTRX Strong Buy
- Analyst Count
- CRVS 4
- MTRX 1
- Target Price
- CRVS $15.00
- MTRX $17.00
- AVG Volume (30 Days)
- CRVS 547.2K
- MTRX 247.6K
- Earning Date
- CRVS 11-11-2025
- MTRX 09-09-2025
- Dividend Yield
- CRVS N/A
- MTRX N/A
- EPS Growth
- CRVS N/A
- MTRX N/A
- EPS
- CRVS N/A
- MTRX N/A
- Revenue
- CRVS N/A
- MTRX $769,286,000.00
- Revenue This Year
- CRVS N/A
- MTRX $25.36
- Revenue Next Year
- CRVS N/A
- MTRX $7.53
- P/E Ratio
- CRVS N/A
- MTRX N/A
- Revenue Growth
- CRVS N/A
- MTRX 5.64
- 52 Week Low
- CRVS $2.54
- MTRX $9.33
- 52 Week High
- CRVS $10.00
- MTRX $16.11
- Technical
- Relative Strength Index (RSI)
- CRVS 56.88
- MTRX 36.45
- Support Level
- CRVS $5.64
- MTRX $12.61
- Resistance Level
- CRVS $6.09
- MTRX $15.02
- Average True Range (ATR)
- CRVS 0.34
- MTRX 0.67
- MACD
- CRVS -0.05
- MTRX -0.23
- Stochastic Oscillator
- CRVS 50.00
- MTRX 18.25
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About MTRX Matrix Service Company
Matrix Service Co is an engineering and construction provider for large industrial projects, primarily in the oil and gas, power, petrochemical, industrial, mining, and minerals markets. It offers engineering, fabrication, construction, and maintenance services, operating across three segments namely Utility and Power Infrastructure; Process and Industrial Facilities; and Storage and Terminal Solutions.